Your browser doesn't support javascript.
loading
Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer.
Yang, Yang; Yuan, Hongyu; Zhao, Lianmei; Guo, Shichao; Hu, Sijun; Tian, Miaomiao; Nie, Yongzhan; Yu, Jiarui; Zhou, Chaoxi; Niu, Jian; Wang, Guiying; Song, Yongmei.
Afiliación
  • Yang Y; Key Laboratory of Cancer and Microbiome, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Yuan H; The Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.
  • Zhao L; Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050051, China.
  • Guo S; Key Laboratory of Cancer and Microbiome, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Hu S; Research center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
  • Tian M; Key Laboratory of Cancer and Microbiome, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Nie Y; State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, 710000, China.
  • Yu J; State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, 710000, China.
  • Zhou C; State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, 710000, China.
  • Niu J; Key Laboratory of Cancer and Microbiome, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Wang G; The Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.
  • Song Y; The Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.
Cell Death Differ ; 29(11): 2177-2189, 2022 11.
Article en En | MEDLINE | ID: mdl-35484333
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / MicroARNs Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Death Differ Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / MicroARNs Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Death Differ Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido